Literature DB >> 1970483

Intestinal microflora: metabolism of drugs and carcinogens.

B R Goldin1.   

Abstract

The intestinal microflora are capable of performing a wide variety of metabolic transformations. The digestive tract can be exposed to orally ingested, bile excreted, or blood-borne exogenous and endogenous substances that can be converted by the intestinal flora into carcinogens, mutagens, cocarcinogens or tumor promoting agents. In addition, the intestinal microflora can metabolize a wide variety of pharmacological agents resulting in production of metabolites required for the physiological activity of these agents or conversely in the inactivation of these agents. This article reviews the current knowledge of the relationship between the intestinal microflora and the metabolic reactions leading to the transformation of drugs and the production of mutagenic or carcinogenic compounds. The composition and distribution of bacteria in the gastrointestinal tract is discussed and the type of reactions these bacteria perform is summarized. The conversion of specific substrates such as, rutin, digoxin, cycasin, azulfidine and cyclamate are discussed and the physiological implication of these conversions are presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970483     DOI: 10.3109/07853899009147240

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  16 in total

Review 1.  Functional analysis of colonic bacterial metabolism: relevant to health?

Authors:  Henrike M Hamer; Vicky De Preter; Karen Windey; Kristin Verbeke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-20       Impact factor: 4.052

2.  Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Authors:  B R Goldin; S L Gorbach; M Saxelin; S Barakat; L Gualtieri; S Salminen
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  Community health care: therapeutic opportunities in the human microbiome.

Authors:  Justin L Sonnenburg; Michael A Fischbach
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

Review 4.  Non-nutritive Sweeteners and Glycaemic Control.

Authors:  Yoona Kim; Jennifer B Keogh; Peter M Clifton
Journal:  Curr Atheroscler Rep       Date:  2019-11-19       Impact factor: 5.113

5.  Identification of a new subfamily of sulphotransferases: cloning and characterization of canine SULT1D1.

Authors:  C Tsoi; C N Falany; R Morgenstern; S Swedmark
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

6.  An Advanced Bioreactor Simulating Dynamic Physiological Conditions in the Human Ascending Colon: MimiCol3.

Authors:  Regine Beeck; Annemarie Dols; Felix Schneider; Dariah-Sohreh Seradj; Julius Krause; Philipp Schick; Werner Weitschies
Journal:  Pharmaceutics       Date:  2022-05-13       Impact factor: 6.525

Review 7.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

8.  Bioavailability and biotransformation of benzo(a)pyrene in an isolated perfused In situ catfish intestinal preparation.

Authors:  K M Kleinow; M O James; Z Tong; C S Venugopalan
Journal:  Environ Health Perspect       Date:  1998-03       Impact factor: 9.031

9.  The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics.

Authors:  Luis Vitetta; Samantha Coulson; Anthony W Linnane; Henry Butt
Journal:  Pathogens       Date:  2013-11-14

Review 10.  Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models.

Authors:  Sheila Annie Peters; Christopher R Jones; Anna-Lena Ungell; Oliver J D Hatley
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.